Hoffmann-la Roche Inc.

Laurene Pousse

Christian Klein

Maria Amann

Ekkehard Moessner

Pablo Umana

Pablo Umaña

Sabine Imhof-Jung

Petra Rueger

Sandra Grau-Richards

Harald Duerr

Alexander Bujotzek

Roland Staack

Johannes Sam

Joerg Zielonka

Estelle Marrer-Berger

Thomas Kraft

Janine Faigle

Dietrich Tuerck

Juergen Peter Bachl

Carina Cantrill

The invention relates to novel bispecific antigen binding molecules, comprising at least two antigen binding domains capable of specific binding to OX40 and a particular antigen binding domain capable of specific binding to Fibroblast Activation Protein (FAP), and to methods of producing these molecules and to methods of using the same.

Bispecific antigen binding molecules targeting OX40 and FAP

The invention relates to bispecific antigen binding molecules comprising (a) at least one moiety capable of specific binding to OX40, and (b) at least one moiety capable of specific binding to epithelial cell adhesion molecule (EpCAM), and to methods of producing these molecules and to methods of using the same.

Bispecific antigen binding molecule for a costimulatory TNF receptor

Growing community of inventors

Schlieren, Switzerland

Laurene Pousse